Non-patented chemotherapy alternative drug may provide cheap chemical cure for cancer: NewsTarget.com

A cheap, simple and safe drug currently being used to treat rare metabolic disorders may be the golden ticket to fighting certain cancers, a Canadian study says. Since it is non-patented, it could be produced on a mass scale by multiple suppliers.

The drug is called Dichloroacetate, or DCA, and it can repair damage to mitochondria affected by cancer, creating large decreases in cancerous tumors. Positive results from the drug were shown in both animal model tests and test tubes. It also has been tested on genetically cultured human cells.

Most importantly, it can kill cancerous cells, including the often unstoppable lung cancer, without affecting other healthy cells and tissues, which differs DCA from many chemotherapies.

Researchers at the University of Alberta in Edmonton, Canada did the tests, finding that in addition to fighting lung cancer, DCA can also decimate brain and breast cancer.

The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:

Non-patented chemotherapy alternative drug may provide cheap chemical cure for cancer

http://www.newstarget.com/021541.html

About NewsTarget

Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.